2. Neuronal Signaling
  3. Amyloid-β
  4. Aducanumab

Aducanumab  (Synonyms: 阿杜那单抗; BIIB037)

目录号: HY-P9967 纯度: 99.25%
COA

摩尔计算器

Aducanumab (BIIB037) 是一种选择性靶向聚集的 β 淀粉样蛋白 (Aβ) 的人单克隆抗体。Aducanumab 显示出脑渗透性，能够用于阿尔茨海默病 (AD) 研究。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

CAS No. : 1384260-65-4

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
1 mg ￥2300
In-stock
5 mg ￥5800
In-stock
10 mg ￥9800
In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Customer Review

Aducanumab 相关抗体

Top Publications Citing Use of Products

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research[1].

同型

Human IgG1 kappa
推荐同型对照抗体
种属

Human
体内研究
(In Vivo)

Aducanumab (30 mg/kg，腹腔注射，单剂量) 在 22 个月大的 Tg2576 转基因小鼠中结合所有形态类型的脑 Aβ 斑块，包括弥漫性 Aβ 沉积和致密性 Aβ 斑块[1]。
Aducanumab (0.3-30 mg/kg, 腹腔注射, 每周一次, 6 个月) 在 9.5 到 15.5 个月大的 Tg2576 转基因小鼠中以剂量依赖性方式减少可溶性和不溶性 Aβ[1]。
Aducanumab (10 mg/kg, 腹腔注射, 每周, 6 个月) 可将 18 个月大的 Tg2576 小鼠的细胞内钙恢复至控制水平[2]。
Aducanumab (0.4-1 mg/mL, 脑室注射, 20 分钟) 在 Tg2576 小鼠中可导致淀粉样蛋白负荷快速减少，从而促进斑块清除[2]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 9.5- to 15.5-month-old Tg2576 transgenic mice [1]
Dosage: 0.3-30 mg/kg
Administration: Intraperitoneal injection (i.p.), weekly, 6 months
Result: Increased recruitment of Iba-1-positive microglia to Aβ plaques.
Animal Model: 18-month-old Tg2576 mice[2]
Dosage: 10 mg/kg
Administration: Intraperitoneal injection (i.p.), weekly, 6 months
Result: Restored neurite baseline calcium to control levels.
Decreased the number of neurites with elevated levels of calcium after 2 weeks.
Decreased the percentage of cell bodies with calcium overload.
Restored the levels of VILIP and SERCA to control levels.
Increased the cell numbers of NR1 and NR2A.
Animal Model: 22-month-old transgenic Tg2576 mice[2]
Dosage: 0.4-1 mg/mL
Administration: Intracerebroventricular injection (ICV), 20 min
Result: Decreased the number of amyloid plaque.
Decreased the size of the remaining individual plaques.
Reduced amyloid plaque burden.
Clinical Trial
CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

阿杜那单抗
运输条件

Shipping with dry ice.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • Human IgG1 kappa
纯度 & 产品资料

纯度: 99.25%

COA (172 KB)

抗体抑制剂使用指南 (1152 KB)
参考文献

Aducanumab 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Aducanumab1384260-65-4BIIB037阿杜那单抗BIIB 037BIIB-037Amyloid-ββ-amyloid peptideAβAbetaamyloid betahuman monoclonal antibodyAlzheimer's diseasebrain penetrationInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Aducanumab
目录号：
HY-P9967
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z